1. Translational roadmap for regenerative therapies of eye disease.
- Author
-
Levin LA, Chiang MF, Dyer MA, Greenwell TN, Svendsen CN, Tumminia SJ, Van Gelder RN, and Wong RO
- Subjects
- Humans, Translations, Eye Diseases therapy, Retinal Neurons
- Abstract
The translation of regenerative therapies to neuronal eye diseases requires a roadmap specific to the nature of the target diseases, patient population, methodologies for assessing outcome, and other factors. This commentary focuses on critical issues for translating regenerative eye therapies relevant to retinal neurons to human clinical trials., Competing Interests: Declaration of interests L.A.L. serves as consultant to Prilenia, Janssen, Roche, Neuroptika, Perfuse, Genentech, UNITY, Eyevensys, Annexon, and Santen., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF